Project Number GC-2013749 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2017 View Full Project Details for Optimization of selective DYRK1A inhibitors as a treatment for AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator HULME, CHRISTOPHER Principal Investigator First Name CHRISTOPHER Principal Investigator Last Name HULME Awardee Organization UNIVERSITY OF ARIZONA Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement Preclinical RFP FY Overall Cost $99,964 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
